Inovio PharmaceuticalsInovio Pharmaceuticals (NSDQ:INO) shares dipped after hours today after the company presented its fourth-quarter earnings and touted clinical trial results.

INO shares finished the day up 4.5% at $11.60 per share but have since dropped -2.2% after hours to $11.35 per share.

The Plymouth Meeting, Pa.-based company posted losses of -$24.3 million, or -14¢ per share, on sales of $5.6 million for the three months ended Dec. 31, 2020, for a 35.5% bottom-line gain on massive sales growth from revenues of just $279,000 in the fourth quarter of 2019.

Get the full story at our sister site, Drug Delivery Business News.